Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / GENOMIC BIOTECH
-
Total 13F shares
-
1,461,926
-
Share change
-
-862,613
-
Total reported value
-
$12,323,285
-
Price per share
-
$8.43
-
Number of holders
-
50
-
Value change
-
-$6,993,716
-
Number of buys
-
17
-
Number of sells
-
32
Institutional Holders of GLOBAL X FDS - GENOMIC BIOTECH (GNOM) as of Q2 2025
As of 30 Jun 2025,
GLOBAL X FDS - GENOMIC BIOTECH (GNOM) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,461,926 shares.
The largest 10 holders included
FLOW TRADERS U.S. LLC, LPL Financial LLC, BANK OF AMERICA CORP /DE/, TWO SIGMA INVESTMENTS, LP, OPPENHEIMER ASSET MANAGEMENT INC., IHT Wealth Management, LLC, UBS Group AG, Insight Advisors, LLC/ PA, Stratos Wealth Partners, LTD., and One Capital Management, LLC.
This page lists
51
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.